SEC Form 4 · accession 0000899243-16-022931
Dicerna Pharmaceuticals Inc · DRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin I Freed
Director
Period of report
Jun 14, 2016
Accepted (ET)
Jun 15, 2016 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001399529
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $3.26 | Jun 14, 2016 | A | 25,000 | A | — | Jun 14, 2026 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The option vests as to one-third of the underlying shares on June 14, 2017 and as to the remaining two-thirds of the shares in eight quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each such date.